Hiltje De Graaf
Leeuwarden, FR, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancer.
Journal: JNCI cancer spectrum
Published: July 05, 2023
Extended adjuvant aromatase inhibition after sequential endocrine therapy in postmenopausal women with breast cancer: follow-up analysis of the randomised phase 3 DATA trial.
Journal: EClinicalMedicine
Published: December 20, 2022
Quality of life and illness perceptions in patients with breast cancer using a fasting mimicking diet as an adjunct to neoadjuvant chemotherapy in the phase 2 DIRECT (BOOG 2013-14) trial.
Journal: Breast cancer research and treatment
Published: August 03, 2020
Secondary analyses of the randomized phase III Stop&Go study: efficacy of second-line intermittent versus continuous chemotherapy in HER2-negative advanced breast cancer.
Journal: Acta oncologica (Stockholm, Sweden)
Published: March 07, 2020
Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial.
Journal: Nature communications
Published: December 17, 2019
Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trial.
Journal: Breast cancer research and treatment
Published: October 29, 2019
Assessment and management of bone health in women with early breast cancer receiving endocrine treatment in the DATA study.
Journal: International journal of cancer
Published: December 02, 2018
Intermittent versus continuous first-line treatment for HER2-negative metastatic breast cancer: the Stop & Go study of the Dutch Breast Cancer Research Group (BOOG).
Journal: Breast cancer research and treatment
Published: July 25, 2018
Efficacy of anastrozole after tamoxifen in early breast cancer patients with chemotherapy-induced ovarian function failure.
Journal: International journal of cancer
Published: April 18, 2018
Ovarian Function Recovery During Anastrozole in Breast Cancer Patients With Chemotherapy-Induced Ovarian Function Failure.
Journal: Journal of the National Cancer Institute
Published: December 09, 2016
Patients homozygous for DPYD c.1129-5923C>G/haplotype B3 have partial DPD deficiency and require a dose reduction when treated with fluoropyrimidines.
Journal: Cancer chemotherapy and pharmacology
Published: June 26, 2016
Last Updated: 09/26/2026